Hansoh Pharmaceutical Investor Relations Material

Hansoh Pharmaceutical Group is a Chinese pharmaceutical company focused on the research, development, manufacturing, and commercialization of innovative and generic drugs. The company’s product portfolio covers therapeutic areas such as oncology, central nervous system (CNS) disorders, anti-infectives, and diabetes. Hansoh Pharmaceutical places a strong emphasis on innovation, investing in R&D to expand its pipeline with both novel and high-quality generic drugs to address unmet medical needs. The company is headquartered in Lianyungang, China, and its shares are listed on the Hong Kong Stock Exchange.